Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DNA methylation as a new tool for the differential diagnosis between T-LBL and lymphocyte-rich thymoma.
Latiri M, Belhocine M, Smith C, Garnier N, Balducci E, Pinton A, Andrieu GP, Bruneau J, Spicuglia S, Jamain S, Latapie V, de Montpreville VT, Chalabreysse L, Marx A, Girard N, Besse B, Plass C, Gibault L, Badoual C, Macintyre E, Asnafi V, Molina TJ, Touzart A. Latiri M, et al. Among authors: plass c. J Pathol. 2024 Nov;264(3):284-292. doi: 10.1002/path.6346. Epub 2024 Sep 27. J Pathol. 2024. PMID: 39329449
TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
Smith C, Goyal A, Weichenhan D, Allemand E, Mayakonda A, Toprak U, Riedel A, Balducci E, Manojkumar M, Pejkovska A, Mücke O, Sollier E, Bakr A, Breuer K, Lutsik P, Hermine O, Spicuglia S, Asnafi V, Plass C, Touzart A. Smith C, et al. Among authors: plass c. Haematologica. 2023 May 1;108(5):1259-1271. doi: 10.3324/haematol.2022.281583. Haematologica. 2023. PMID: 36632736 Free PMC article.
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.
Smith C, Touzart A, Simonin M, Tran-Quang C, Hypolite G, Latiri M, Andrieu GP, Balducci E, Dourthe MÉ, Goyal A, Huguet F, Petit A, Ifrah N, Baruchel A, Dombret H, Macintyre E, Plass C, Ghysdael J, Boissel N, Asnafi V. Smith C, et al. Among authors: plass c. Mol Cancer. 2023 Jan 18;22(1):12. doi: 10.1186/s12943-022-01701-x. Mol Cancer. 2023. PMID: 36650499 Free PMC article.
Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors.
Faucz FR, Horvath AD, Assié G, Almeida MQ, Szarek E, Boikos S, Angelousi A, Levy I, Maria AG, Chitnis A, Antonescu CR, Claus R, Bertherat J, Plass C, Eng C, Stratakis CA. Faucz FR, et al. Among authors: plass c. Endocr Relat Cancer. 2023 Sep 11;30(10):e230067. doi: 10.1530/ERC-23-0067. Print 2023 Oct 1. Endocr Relat Cancer. 2023. PMID: 37578265 Free PMC article.
SRSF2 safeguards efficient transcription of DNA damage and repair genes.
Wagner RE, Arnetzl L, Britto-Borges T, Heit-Mondrzyk A, Bakr A, Sollier E, Gkatza NA, Panten J, Delaunay S, Sohn D, Schmezer P, Odom DT, Müller-Decker K, Plass C, Dieterich C, Lutsik P, Bornelöv S, Frye M. Wagner RE, et al. Among authors: plass c. Cell Rep. 2024 Nov 26;43(11):114869. doi: 10.1016/j.celrep.2024.114869. Epub 2024 Oct 23. Cell Rep. 2024. PMID: 39446588 Free article.
457 results